Inactive Ingredient Search for Approved Drug Products
You are Searching: Change and Deletion by Inactive Ingredient Name Beginning with H
| Quarter | Inactive Ingredient | Route of Administration | Dosage Form | Maximum Potency per unit dose | Maximum Daily Exposure | Status | |
|---|---|---|---|---|---|---|---|
| Q4 2023 | HYDROCHLORIC ACID | OPHTHALMIC | SOLUTION | 0.59 %w/v | Correction | ||
| Q1 2024 | HYDROCHLORIC ACID | OPHTHALMIC | SOLUTION | 0.31 %w/v | Correction | ||
| Q4 2023 | HYPROMELLOSE | OPHTHALMIC | SOLUTION/ DROPS | 0.50 %w/v | Correction | ||
| Q1 2024 | HYPROMELLOSE | OPHTHALMIC | SOLUTION/ DROPS | 0.10 %w/v | Correction | ||
| Q4 2023 | HYPROMELLOSE | ORAL | CAPSULE, DELAYED RELEASE | 669mg | Correction | ||
| Q1 2024 | HYPROMELLOSE | ORAL | CAPSULE, DELAYED RELEASE | 105mg | Correction | ||
| Q1 2024 | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | BUCCAL | GUM, CHEWING | 27.92 mg | Deletion | ||
| Q1 2024 | HYPROMELLOSE 2906 (4000 MPA.S) | ORAL | TABLET, EXTENDED RELEASE | 17.00 mg | 34mg | Deletion | |
| Q1 2024 | HYPROMELLOSE 2910 (5 MPA.S) | OPHTHALMIC | SOLUTION | 0.10 %w/v | Deletion | ||
| Q1 2024 | HYPROMELLOSE PHTHALATE | ORAL | GRANULE, FOR SUSPENSION | 304.30 mg/ 5.00 ml | Deletion | ||
| Q4 2023 | HYPROMELLOSE 2910 (4000 MPA.S) | OPHTHALMIC | SOLUTION/ DROPS | 0.50 %w/v | MDE Replacement | ||
| Q1 2024 | HYPROMELLOSE 2910 (4000 MPA.S) | OPHTHALMIC | SOLUTION/ DROPS | 3mg | MDE Replacement |
FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections: IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly
Data Through: January 5, 2024
Database Last Updated: January 26, 2024